Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?

Background: Low-dose rivaroxaban and low-intensity warfarin are widely used in Asia for patients with atrial fibrillation (AF). However, in Asians, it is unclear whether low-dose rivaroxaban and low-intensity warfarin can improve the prognosis of AF. In this study, we investigate the survival benefi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Dong, Chen, Yequn, Yong, Jian, Wu, Shiwan, Zhou, Yan, Li, Weiping, Tan, Xuerui, Liu, Ruisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655790/
https://www.ncbi.nlm.nih.gov/pubmed/34901228
http://dx.doi.org/10.3389/fcvm.2021.768730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655790/
https://www.ncbi.nlm.nih.gov/pubmed/34901228
http://dx.doi.org/10.3389/fcvm.2021.768730

Ejemplares similares